All posts by imreal

Technology: Computer

Anchor Stablecoin is Now Live and Available for Trading on IDEX Exchange

Leave a comment


Anchor’s token listing on IDEX, one of the world’s leading decentralized exchanges, marks an important milestone in our promise to provide a scalable and viable alternative to fiat-pegged stablecoins to crypto traders, businesses, governments, and individuals around the world.


NEW YORK (PRWEB)

Anchor (ANCT), a two-token, algorithmic stablecoin pegged to the sustainable and predictable growth trend of the global economy, is now listed and available for trading on IDEX, the world’s leading decentralized cryptocurrency exchange. IDEX provides retail and institutional traders with a secure, trustless, and real-time trading experience backed by transparent blockchain settlements.

Following Anchor’s token launch on Liquid in August, IDEX is the second exchange to list the stablecoin offering ANCT for purchasing, selling, and trading to crypto traders, investors, and stablecoin enthusiasts. ANCT offers token users a hedge against daily market volatility, long-term price stability with steady appreciation over time, ease of fiat currency on-ramp and off-ramp, and liquidity.

IDEX CEO Alex Wearn said, “Next-generation stablecoins like Anchor (ANCT) hold a promising future. We’re excited to play a part in unlocking more diverse financial services and options for our traders.”

Anchor Founder and CEO Daniel Popa stated, “Anchor’s token listing on IDEX, one of the world’s leading decentralized exchanges, marks an important milestone in our promise to provide a scalable and viable alternative to fiat-pegged stablecoins to crypto traders, businesses, governments, and individuals around the world. As the first to market a new category of digital global currencies, Anchor is uniquely independent from any fiat currency’s value and is pegged 1-to-1 with the Monetary Measurement Unit (MMU), a non-flationary financial index, which reflects the sustainable growth of the global economy.”

A two-token, algorithmic stablecoin, Anchor is pegged to global economic growth via the Monetary Measurement Unit (MMU). The MMU is a non-flationary financial index created by an algorithm that tracks a series of macroeconomic indicators to provide the most accurate, available measure of real value that exists in the world today.

Stablecoins backed by fiat are susceptible to the same market fluctuations, depreciation, and loss of purchasing power as their traditional counterparts to which they are pegged. The global economy, on the other hand, has a sustainable and predictable growth trend with global GDP steadily increasing over time. Providing an alternative to fiat-pegged stablecoins, Anchor will remain stable regardless of any fiat currency’s strength, market fluctuations, or economic recessions.

Anchor’s next-generation tokenomics incorporates an elastic supply rule that adjusts the quantity of coin supply proportionately to changes in Anchor’s market value with a two-token, burn-mint model that adheres to naturally occurring Contraction and Expansion Phases. Anchor Tokens (ANCT) serve as the main currency/payment tokens, while Dock Tokens (DOCT) serve as the utility tokens that ensure ANCT remains pegged to the MMU regardless of external market fluctuations.

Beyond trading, Anchor’s stablecoin could be leveraged to significantly reduce fees and transaction times when sending remittances or making international payments via wire transfer or credit card. The unbanked can join the Anchor Economy simply by downloading the Anchor Wallet to a mobile phone, which enables funds to be stored, sent, and received without value lost due to transaction fees. Furthermore, Anchor’s financial index, the MMU, has the potential to become a new financial standard and an ideal value peg for countries issuing their own sovereign cryptocurrencies, such as the Marshall Islands along with 18 other countries creating or researching the issuance of a decentralized digital currency.

In addition, Anchor is planning to enter its first round of fundraising and will be offering traditional equity in exchange for financing from institutional investors, VCs, and private equity firms. Chief Communications Officer, Olya Moskalenko will be available to meet with interested parties during Invest: NYC at the New York Marriott Marquis between November 11th – 13th.

Users can purchase and trade Anchor (ANCT) on IDEX now by signing up or logging into their IDEX accounts and following this link: https://idex.market/eth/anct

Please note, trading ANCT on IDEX from the United States is currently unavailable.

—-

For media inquiries, please contact:

Olya Moskalenko

Chief Communications Officer

olya.moskalenko(at)theanchor.io

Kili Wall

Melrose PR Account Executive

Kili(at)melrosepr.com

+1 (310) 260-7901

About Anchor

Anchor is a stablecoin cryptocurrency pegged to a non-flationary, algorithmic index that reflects the long-term growth of the global economy. The Monetary Measurement Unit (MMU) algorithm is based on the GDP of more than 190 countries and further stabilized with FX indicators from a basket of eight currencies, and premium sovereign bond yields from 10 of the world’s strongest economies. Offering the stablecoin market an alternative to fiat-pegged stablecoins, Anchor’s tokenomics ecosystem is designed to be intrinsically stable with its MMU and safety-net of six stabilizing mechanisms, including a two-token, burn-mint model to ensure stability and equilibrium regardless of market growth or recession. CEO Daniel Popa, a serial telecom and software entrepreneur with over 20 years experience running successful multinational companies, has led a team of PhD economists in developing Anchor’s proprietary MMU. Anchor’s network of partners includes Ambisafe, blockchain infrastructure provider that previously worked with Tether; as well as KYC Spider, a digital KYC compliance tool for financial intermediaries and the fintech industry.

About IDEX

IDEX is the #1 DEX on Ethereum, providing retail and institutional customers with a secure, trustless, and real-time trading experience backed by transparent blockchain settlement. Through a hybrid design that manages trade matching and balance updates off-chain, IDEX eliminates mining delays and enables continuous trading, multiple simultaneous orders, and zero-fee cancellations.

For more information about IDEX, please visit https://idex.market/eth/idex.

Share article on social media or email:

Technology: Electronics

Noblis to Offer Insights on the Potential of Large-scale Autonomous Systems at NVTC Autonomous Technology Summit on Nov. 7

Leave a comment


Noblis award winning, Autonomy at Scale concept is helping realize the vision of trusted autonomous operations allowing connected vehicles to communicate, self-organize and safely interact.

” … The recent launch of our Pieces of Eight (Po8) -Trusted Autonomy program demonstrates how forward-thinking research and technical solutions are helping government and commercial customers solve complex challenges,” said Amr ElSawy, president and chief executive officer, Noblis.


RESTON, Va. (PRWEB)

Researchers from Noblis, a leading provider of science, technology and strategy services to the federal government, will discuss how earned trust and blockchain technology can enable autonomous systems to transform how we travel and deliver goods at the Northern Virginia Technology Council (NVTC) Autonomous Technology Summit on Nov. 7, at the INOVA Center for Personalized Health in Fairfax.

The summit, in partnership with the Virginia Unmanned Systems Center at CIT, will feature experts from commercial, defense, regulatory and academic sectors discussing the opportunities, challenges and impacts of autonomous technology, and showcase Virginia’s leadership in autonomous systems. More information on the summit is available at: https://autonomous.nvtc.org/

“We are delighted to be part of NVTC’s summit,” said Amr ElSawy, president and chief executive officer, Noblis. “One of the many research efforts Noblis has undertaken in the past few years is to study the effects of autonomy on a larger scale across air, sea, land, space, and cyber domains. The recent launch of our Pieces of Eight (Po8) -Trusted Autonomy program demonstrates how forward-thinking research and technical solutions are helping government and commercial customers solve complex challenges.”

The Noblis Po8 trusted autonomous operations concept has received significant recognition since its public release. It will be recognized with a 2019 Government – Industry Innovator award from 1105 Public Sector Media Group on Nov. 7; and it earned the Highest Potential Impact Award and the Most Creative Award at the MOBI (mobility open blockchain initiative) Grand Challenge in Munich, Germany in February 2019.

At the summit, Noblis’ Karl Wunderlich, director of surface transportations systems, will offer a keynote on the transformative benefits of autonomous systems, heterogenous, unfamiliar and connected machines and their need to self-organize and develop relationships that are similar to human trust – but also fundamentally different. Noblis researcher Drew Dudash will participate in a panel and share insights on how blockchain technology allows unfamiliar, heterogenous machines to form ad hoc, many-to-many relationships with each other and the surrounding IoT ecosystem, and how it can improve cybersecurity.

ABOUT NOBLIS

Noblis is a dynamic science, technology, and strategy organization dedicated to creating forward-thinking technical and advisory solutions in the public interest. We bring the best of scientific thought, management, and engineering expertise together in an environment of independence and objectivity to deliver enduring impact on federal missions. Noblis works with a wide range of government clients in the defense, intelligence and federal civil sectors. Together with our wholly owned subsidiary, Noblis ESI, we tackle the nation’s toughest problems and support our clients’ most critical missions.

Share article on social media or email:

health and fitness

2019 CFLD Beijing Marathon – A Gift of Celebration

Leave a comment



TIANANMEN SQUARE, China (PRWEB)

The cool autumn morning of November 3rd, at 7:30, in Tiananmen Square, one of the largest public squares in the world, echoed the starting signal of the top marathon event in China.

This year, the organizers received over 160,000 applications for the event, 30,000 runners from around the world eventually took part in the race.

At the end of this much anticipated running event, Mathew Kipkoech Kisorio from Kenya was the first broke through the finishing line, took this year’s champion title in men’s category with the time of 2:07:06; Solomon Kirwa Yego and Emmanuel Rutto Naibei following through with times of 2:09:45 and 2:10:15, taking the 2nd and 3rd place respectively.

In women’s category, Sutume Asefa Kebede from Ethiopia won the first place in 2:23:31; Li Zhi Xuan came in 2nd in 2:29:06, and Mulu Seboka Seyfu finished in 3rd in 2:29:09.

To ensure yet another memorable racing experience for all who participated, and in celebration of the nation’s 70th Birthday, organizers provided runners with plenty of supplies to power them throughout the race, including over 400,000 bottles of water, plus energy drinks, energy bars, bananas, cakes, milk and snacks along the racing routes. There were medical stations every 2.5km after the initial 5km mark, and first aid volunteers every 100 meters; 20 ambulances and more than 300 medical personnel were on standby.

http://bit.ly/2Nf5vuH

Text and Photo Credits: CFLD Beijing Marathon

Share article on social media or email:

Industry: Healthcare

New Podcast Sponsored by Asymmetrex Increases Awareness to the Need for Stem Cell Dose in Stem Cell Treatments

Leave a comment


Asymmetrex Sponsors Podcast on “Counting Stem Cells for a New Era of Medicine”

Dose is essential for stem cell medicine as well.


BOSTON (PRWEB)

In October, Massachusetts stem cell biotechnology company Asymmetrex launched a new podcast to provide information to patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical practice, stem cell treatments are given without knowing the dose of the treating stem cells. This problem affects all patients receiving stem cell treatments, including patients receiving approved treatments in routine clinical practice, patients volunteering for experimental treatments in FDA-authorized clinical trials, and patients obtaining unapproved treatments in private stem cell clinics.

The costs and dangers of unknown stem cell dose in treatments are significant. Stem cell clinical trials cannot be interpreted without knowing the treatment dose, leading to huge wastes of both federal and private clinical research dollars. In the case of manufactured stem cells, many treatments may contain very few or no stem cells at all. It is impossible for doctors to improve treatments without knowing the stem cell dose. Stem cell donors for approved treatments like blood stem cell transplantation are scarce. Knowing the stem cell dose would allow doctors to know when a treatment sample has enough stem cells to treat more than one patient; or when it does not have enough to treat even a single patient. In the second case, not knowing the stem cell dose can result in the death of children treated for leukemia when unknowingly they receive an umbilical cord blood transplant with too few blood stem cells to save them.

Earlier this year, the FDA recognized the pressing need for stem cell dose in stem cell medicine. The agency’s Standards Coordinating Body for Regenerative Medicine (SCB) listed stem cell dose determination as a priority for needed standards for stem cell medicine. Dose is a fundamental principle for the discovery, development, and administration of quality medicines. Asymmetrex Director James L. Sherley, M.D., Ph.D., who is featured in the new podcast, says that, “Dose is essential for stem cell medicine as well. The new podcast has the goal of informing the end users of stem cell treatments: the patients, their doctors, their families, and their advocates, including the FDA. When the people most impacted by these treatments understand that knowing the dose of stem cells is just as important as knowing the dose of their other medicines, they will be empowered to demand this essential certification of the integrity of their stem cell treatments.”

The first episode of the podcast, “Counting Stem Cells For A New Era Of Medicine,” aired online on October 17. The third episode of the biweekly, 6-episode series is scheduled for airing November 12. Each episode features an interview of Asymmetrex Director Sherley by podcast producer Jordan Rich. Mr. Rich guides Dr. Sherley through a discussion of questions that reveal the current challenges that Asymmetrex is addressing to achieve full adoption of stem cell dose as a routine practice in stem cell medicine. The series also highlights other significant applications for stem cell counting in drug development and environmental health science. In conjunction with this educational effort, the company is also sponsoring a study on its website to evaluate the current state of public, academic, and industry knowledge of coming changes in stem cell medicine related to the adoption of stem cell dose.

About Asymmetrex

Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s patent portfolio contains biotechnologies that solve the two main technical problems – production and quantification – that have stood in the way of successful commercialization of human adult tissue stem cells for regenerative medicine and drug development. In addition, the portfolio includes novel technologies for isolating cancer stem cells and producing induced pluripotent stem cells for disease research purposes. Asymmetrex markets the first technology for determination of the dose and quality of tissue stem cell preparations (the “AlphaSTEM Test™”) for use in stem cell transplantation therapies and pre-clinical drug evaluations.

Share article on social media or email:

Business: Insurance

Solvang Insurance Agent, Rick Torres, Releases The Top Reasons To Bundle Insurance Coverage

Leave a comment


News Image

When your insurance policies are with the same company, you have a very important benefit and customer commitment that comes with centralized risk assessment.


PASO ROBLES, Calif. (PRWEB)

Combining home or renters insurance with auto insurance makes good sense for the budget but there are other very tangible benefits to bundle insurance policies. Rick Torres, Solvang insurance agent recently released the top reasons for people to consider combining insurance coverage.

It’s not uncommon for people to have auto insurance with one company and homeowners or renters with another. When starting out, a young, single person gets car insurance either through their parents’ insurance or on the recommendation of a friend or a television commercial. Later, when out on their own and they start accumulating furniture and electronics, they may get renter’s insurance to protect their possessions or may be required to carry a minimum policy by a landlord. As life moves along and they start families, buy homes, buy new cars, they continue to shop for the best deals in insurance without investigating the benefits of combining policies.

Aside from the potential savings, someone gets by combining insurance policies, there are other benefits such as:


  • Convenience: The convenience of keeping track of only one due date instead of two or more is a plus in anyone’s busy schedule. Also, consider the fact that there is one number to call with questions or to make a claim.

  • Personal attention: Combining insurance policies with one company means you have an insurance agent who gives your insurance needs personal attention. Regular policy reviews are scheduled to keep your coverage at the best level for your current circumstances. There is only one person to call when life changes your insurance needs. There aren’t many life changes that don’t require a thorough insurance review. Getting married or divorced, having children, a new job or a promotion, graduating college, even buying a home can mean changes to insurance on that paid for 10-year old car you’ve been driving since it was new.

  • Better risk assessment: Changes in life circumstances can mean it’s time for a new risk assessment. Unfortunately, all the good things that come our way in life can leave us vulnerable in the event of accidents. This includes traffic accidents, fender-benders, a visitor tripping and falling on your front porch, your dog playing too rough with the neighbor’s kid and scratching an arm or leg. Even when someone accidentally injured in your vehicle or on your property has the best intentions, medical complications that take the matter beyond anyone’s control can happen.

When your insurance policies are with the same company, you have a very important benefit and customer commitment that comes with centralized risk assessment. An invaluable asset is having one agent who knows your policies and when to make the best recommendations for you.

The Rick Torres Insurance Agency in Solvang, CA is committed to providing policyholders the highest quality of service by making sure individuals and families are insured for the best protection with the least impact on the budget as possible. Call today to find about combining insurance coverage, getting a current risk assessment, and to discover the many other benefits of working with the Rick Torres Insurance Agency.

Rick Torres Insurance Agency, Inc.

540 Alisal Road, Suite 4

Solvang, CA 93463

(805) 688-5418

This press release is by Paso Robles advertising company Access Publishing, 806 9th Street, #2D, Paso Robles, CA 93446, (805) 226-9890.

Share article on social media or email:

Business: Executives

Catalent’s Chair & Chief Executive Officer, John Chiminski, Receives First Ever ‘Lifetime Achievement’ Award at CPhI Worldwide

Leave a comment


Catalent’s Chair & Chief Executive Officer, John Chiminski

Catalent’s Chair & Chief Executive Officer, John Chiminski

I am extremely proud to lead a company of highly talented people who are totally committed to bringing better, innovative treatments to market, in the shortest possible timeframe, ultimately improving patient outcomes.


SOMERSET, N.J. and FRAKFURT, Germany (PRWEB)

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that its Chair and Chief Executive Officer, John Chiminski, has received the inaugural CPhI Pharma Awards ‘Lifetime Achievement Award’ at the world’s largest pharmaceutical exhibition, CPhI Worldwide, currently taking place at Messe Frankfurt, Germany.

The judges considered Mr. Chiminski to be ‘an exceptional individual with a consistent history of service, above and beyond the call of duty’ throughout his career. The award was announced at a Gala Dinner on Tuesday, November 5th. Established in 2004, the CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. The awards celebrate thinkers and creators breaking new ground and strongly advocate companies committed to driving the industry forward.

On receiving the award, Mr. Chiminski commented, “I would like to sincerely thank the judges and my industry peers for this recognition and feel deeply honored.” He added, “I am extremely proud to lead a company of highly talented people who are totally committed to bringing better, innovative treatments to market, in the shortest possible timeframe, ultimately improving patient outcomes.”

Over a 10-year period, Mr. Chiminski has led Catalent’s transformation into the world’s leading drug delivery technology, development and supply organization, overseeing a successful IPO in 2014. Since then he has driven the company’s growth strategy, both organically and through acquisitions, to ensure maximum return on investment for shareholders.

Today, he heads an organization employing nearly 13,000 people, including approximately 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue.

Mr. Chiminski joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles.

He holds a Bachelors of Sciences from Michigan State University and a Master of Sciences from Purdue University, both in electrical engineering, as well as a master’s degree in management from the Kellogg School of Management at Northwestern University.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Health

Genomenon Accelerates Rare and Genetic Disease Research with Mastermind v2.0

Leave a comment


Mastermind Genomic Search Engine, version 2.0

“This new functionality will be invaluable in our ongoing work to diagnose and treat babies with rare diseases.” Shareef Nahas, Rady Children’s Institute for Genomic Medicine.


ANN ARBOR, Mich. (PRWEB)

Genomenon® announced the release of Mastermind® version 2.0 today. The Genomic Search Engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases.

Patients, particularly those with rare diseases, don’t always have a name for their condition. This makes it very difficult to diagnose and treat their disease. The ability to search the genetic literature by symptoms (following the Human Phenotype Ontology, or HPO) helps clinicians narrow their diagnosis to the appropriate disease and treatment.

Genomenon’s Mastermind Genomic Search Engine is the world’s largest and most complete source of genomic evidence. Doctors and researchers use Mastermind to find the scientific evidence relevant to their patients’ DNA profile for diagnostic and therapeutic recommendations. The new release of Mastermind includes a more streamlined search function to help doctors more quickly scour through the millions of research articles to find cases that match their patients’ genomic profile and symptoms.

The ability to search by phenotype was the top feature requested by the children’s hospitals and genetic testing labs that use Mastermind for variant interpretation. A preview of the new version was well received at the American Society for Human Genetics annual meeting in October.

“We are world-renowned for the speed of our WGS (whole genome sequencing) interpretations, and using Mastermind has been a crucial step in accelerating our progress.” said Shareef Nahas, Senior Director of Clinical Operations for Rady Children’s Institute for Genomic Medicine. “This new functionality will be invaluable in our ongoing work to diagnose and treat babies with rare diseases.”

“The ability to search by phenotype gives Mastermind users even more power to discover which genes in a patient’s DNA are most likely to be relevant based on empirical data in the medical literature.” Said Dr. Mark Kiel, co-founder and Chief Science Officer of Genomenon.

About Genomenon

Genomenon connects patient DNA with the billions of dollars spent on research to help doctors diagnose and cure cancer patients and babies with rare diseases. Our flagship product, the Mastermind Genomic Search Engine is used by hundreds of genetic labs worldwide to accelerate diagnosis, increase diagnostic yield and assure repeatability in reporting genetic testing results. We license our Mastermind Curated Genomic Datasets to pharmaceutical and bio-pharma companies to inform precision medicine development, deliver genomic biomarkers for clinical trial target selection, and support CDx regulatory submissions with empirical evidence.

For more information, visit Genomenon.com.

Share article on social media or email:

Legal / Law: Criminal Law

Greenberg Traurig Mexico City Office Named White Collar Crime Law Firm of the Year by The Latin American Lawyer

Leave a comment



MEXICO CITY (PRWEB)

The Mexico City office of global law firm Greenberg Traurig, LLP received the Law Firm of the Year – White Collar Crime Award at The Latin American Lawyer Energy & Infrastructure Awards 2019.

The awards ceremony and dinner took place on Oct. 23 at the JW Marriot in Mexico City, gathering guests from the Energy and Infrastructure legal sectors from numerous Latin American countries. Hugo López Coll, a shareholder in the White Collar Defense & Special Investigations Practice in Mexico City, accepted the award on behalf of the firm.

“We are honored to receive this recognition as a reflection of our commitment to excel in client service,” said López Coll. “Our White Collar Defense & Special Investigations Practice has consistently been ranked as one of the strongest, not only in Mexico and Latin America, but globally. Our global practice utilizes the significant knowledge of veterans in related fields across the firm to develop and integrate global strategies for our clients.”

The event aims to highlight the excellence of lawyers in firms who are experts in the energy and infrastructure sector in Latin America. Winners were selected by a jury composed of general counsels from leading industry companies in the region, according to the publisher.

“We are very pleased to receive this award, as it reflects our attorneys’ commitment to our clients throughout Latin America,” said the Co-Chairs of Greenberg Traurig’s Global White Collar Criminal Defense Practice Nathan J. Muyskens and Barry Vitou in a joint statement. “We have handled many high-profile criminal cases in Mexico and Latin America, and look forward to continuing our role as strong advocates for all of our clients in the region.”

López Coll advises Mexican and regional entities and their holding companies, both in regulated and non-regulated industries, on regulatory and compliance matters with Mexican laws, and assists clients with issues arising under the laws comprising the Mexican National Anti-Corruption System, the Foreign Corrupt Practices Act (FCPA), the OECD Convention, and the UN Convention Against Corruption. He also represents domestic and international clients on mergers and acquisitions, private equity, regulatory and compliance matters, internal investigations, shareholders’ disputes, and gaming issues.

About Greenberg Traurig’s White Collar Defense & Special Investigations Practice: Greenberg Traurig’s White Collar Defense & Special Investigations Practice protects companies and individuals under government scrutiny. GT’s creative defense lawyers in the US, Europe, Latin America, and Asia Pacific are at the forefront of white collar defense, with wide-ranging experience in structuring internal investigations, developing guidelines, implementing compliance programs, and addressing issues of voluntary disclosure. Their representations involve alleged securities and commodities fraud, Foreign Corrupt Practices Act (FCPA) violations, health care/pharmaceutical fraud, environmental crimes, money laundering, financial services fraud, public corruption/campaign finance, tax corruption, defense contracting, and bankruptcy fraud. In addition, the majority of GT’s litigation shareholders and counsel have first-chair trial experience.

About Greenberg Traurig Mexico: Greenberg Traurig’s Mexico City office offers clients innovative, strategic advice and legal services that span both traditional fields and contemporary regulatory sectors. The office has more than 60 bilingual attorneys who have been contributors to major national projects in Mexico and leverages the resources and reach of the firm’s global platform to provide clients with tailored legal services reflective of the specific industry and market conditions in which they operate. The Mexico City office is an integral part of the firm’s award-winning Latin America Practice, and has been recognized with leading banking, corporate, M&A, infrastructure, real estate, privacy, energy, administrative litigation, and competition practices in Mexico.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:



Society: Christianity

Margaret Ann Fiore’s newly released “The Radiance of Christ” is a profound and personal read that shows the beauty and true meaning of being a priest

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“The Radiance of Christ: The Priesthood of Monsignor Kenneth W. Roeltgen”: a touching biography of a promising priest in pages that speak about his extraordinary life in faith and service. “The Radiance of Christ: The Priesthood of Monsignor Kenneth W. Roeltgen” is the creation of published author Margaret Ann Fiore, a nurse practitioner for over four decades. She serves on the Rector’s Council of Mount St. Mary’s Seminary in Emmitsburg, Maryland. She was also the third president of the American Association of Neuroscience Nurses and founded the Brain Tumor Support Group in the Metropolitan Washington area. Additionally, she has written several scholarly papers on the science and practical management of patients with neurological tumors that she presented to distinguished audiences worldwide.

Fiore shares, “The memory of Msgr. Roeltgen has not been dimmed by time. Those who knew him and were trained to virtue by his precepts and example love to speak of him, to repeat his words, and tell incidents of his holy life.

“Monsignor’s life and character had a beauty few achieve. The gentleness of his manner, the strength of his character, the validity of his priestly commitment, and the unswerving love of God, the Church, the priesthood and, of course, his brother priests and his parishioners were so apparent to all who knew him that we knew we experienced a rare blessing and were especially gifted by the Lord in him.

“This book will be of immense spiritual value to all who know and want to know God, and will strengthen their faith, hope, and charity in these days when there is an apparent conspiracy at work to erase the consciousness of God from the minds of men.

“‘We are but high up old windows through which the grace of God still shines.’ This sentence aptly describes our much loved and deeply missed friend. Monsignor Roeltgen was, indeed, a man who let the light of God shine through.”

Published by Christian Faith Publishing, Margaret Ann Fiore’s new book is a great preservation of the life of a good and holy priest that will also inspire others who wish to serve God and His people. This creation is also a wonderful gift to seminarians, priests, laity, and everyone who acknowledges the commitment of men to the holy priesthood.

View a synopsis of “The Radiance of Christ: The Priesthood of Monsignor Kenneth W. Roeltgen” on YouTube.

Consumers can purchase “The Radiance of Christ: The Priesthood of Monsignor Kenneth W. Roeltgen” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “The Radiance of Christ: The Priesthood of Monsignor Kenneth W. Roeltgen,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Technology: Computer

KnowBe4 Brings Security Awareness Training to the State of Texas Thanks to New Certified Status

Leave a comment


News Image

Government organizations really need this type of training to build up their human firewall, which will help to protect them against the ongoing problem of social engineering. -Stu Sjouwerman, CEO, KnowBe4


TAMPA BAY, Fla. (PRWEB)

KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced that it is now certified by the Texas Department of Information Resources for state and local government employees in Texas.

House Bill 3834 (86R) was created to require that state and local government employees take mandatory cybersecurity training to help better protect the government. It requires that the Texas Department of Information Resources, in consultation with the Texas Cybersecurity Council, certify cybersecurity training programs for state and local government employees. KnowBe4 has been selected to be certified. The course requirements include a focus on information security habits and procedures that protect information resources and teach best practices for detecting, assessing, reporting and addressing information security threats.

“We’re excited for the opportunity to bring our security awareness training and simulated phishing to more of the government employees who work for the state of Texas,” said Stu Sjouwerman, CEO, KnowBe4. “State and local governments have been making headlines recently due to an onslaught of ransomware attacks. Government organizations really need this type of training to build up their human firewall, which will help to protect them against the ongoing problem of social engineering.”

An organization can measure its Phish-proneTM Percentage, which indicates how many of their employees are likely to fall for a phishing or social engineering scam, to evaluate the security mindset of its employees. Every organization regardless of size and vertical is susceptible to phishing and social engineering without computer-based training. The average initial baseline Phish-prone Percentage is around 30% and after one year of testing and simulated phishing, drops down to just 2%.

For more information on KnowBe4, visit http://www.knowbe4.com.

Share article on social media or email: